Skip to main content
. 2020 Aug 19;9(7):440–449. doi: 10.1302/2046-3758.97.BJR-2019-0325.R2

Table I.

Clinical and laboratory characteristics of study subjects.

Characteristic Prosthetic joint infection (n = 49) Noninfection (n = 21) p-value
Mean age, yrs (SD) 66.0 (13.8) 64.9 (12.2) 0.739*
Sex, n (%) 0.156
Male 30 (61.2) 9 (42.9)
Female 19 (39.8) 12 (57.1)
Site of arthroplasty, n (%) 0.676
Knee 26 (53.1) 10 (47.6)
Hip 23 (46.9) 11 (52.4)
Mean body mass index, kg/m2 (SD) 27.6 (4.8) 28.3 (4.8) 0.537*
Surgical procedure, n (%) 0.525
Debridement with implant retention 12 (24.5) 3 (14.3)
Revision with implant resection 37(75.5) 18 (85.7)
Antibiotics received two weeks prior to surgery, n (%) 18 (36.7) 4 (19.0) 0.144
Clinical and laboratory findings
Presence of sinus tract, n (%) 12 (22.6) 0 (0.0) < 0.001
Positive synovial fluid,≥ two periprosthetic tissue cultures, n (%) 36 (73.5) 1 (4.8) < 0.001
Mean synovial fluid white blood-cell count, cells/ml (SD) 58,780.8 (101176.1) 906.5 (548.3) 0.011
Mean synovial fluid polymorphonuclear neutrophils, % (SD) 79.7 (13.0) 44.4 (17.0) < 0.001
Mean serum CRP, mg/l (SD) 47.4 (41.4) 9.6 (7.1) < 0.001
Mean serum ESR, mm/hr (SD) 67.6 (34.2) 13.5 (5.6) < 0.001
Acute inflammation in periprosthetic tissue histopathology, n (%) 24 (75.0) 0 (0) < 0.001
*

Independent-samples t-test.

Chi-squared test.

Mann-Whitney U test.